Skip to main content

Advertisement

Log in

The Radiologically Isolated Syndrome: Look (Again) Before You Treat

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

The advent and wide use of magnetic resonance brain imaging has led to in the unexpected detection of lesions that appear typical of multiple sclerosis (MS) in otherwise asymptomatic patients. Several cohorts of patients with the “radiologically isolated syndrome (RIS)” have been studied mainly retrospectively, and a proportion of them do go on to have clinical symptoms of MS. This has led to the not infrequent clinical conundrum of whether or not to treat patients with MRI lesions suggestive of MS, given the knowledge that MS disease-modifying therapies work best when given early in the disease course. However, the decision to proactively treat patients with RIS is countered by the increasing risks associated with MS disease-modifying therapies as well as the uncertain prognostic outcome of RIS. This review will highlight what is and is not known about the long-term outcomes of RIS and present recommendations for clinicians when faced with this challenging situation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. PRISMS Study Group and the University of British Columbia MS/MRI Analysis Group: PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology 2001;56(12):1628–36.

    Google Scholar 

  2. Uitdehaag B, Constantinescu C, Cornelisse P, et al. Impact of exposure to interferon beta-1a on outcomes in patients with relapsing-remitting multiple sclerosis: exploratory analyses from the PRISMS long-term follow-up study. Ther Adv Neurol Disord. 2011;4(1):3–14.

    Article  PubMed  CAS  Google Scholar 

  3. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227–31.

    Article  PubMed  CAS  Google Scholar 

  4. Paty DW, Oger JJ, Kastrukoff LF, et al. MRI in the diagnosis of MS: a prospective study with comparison of clinical evaluation, evoked potentials, oligoclonal banding, and CT. Neurology. 1988;38(2):180–5.

    PubMed  CAS  Google Scholar 

  5. Comi G, Filippi M, Barkhof F, et al. Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet. 2001;357(9268):1576–82.

    Article  PubMed  CAS  Google Scholar 

  6. Jacobs LD, Beck RW, Simon JH, et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med. 2000;343(13):898–904.

    Article  PubMed  CAS  Google Scholar 

  7. Kappos L, Polman CH, Freedman MS, et al. Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes. Neurology. 2006;67(7):1242–9.

    Article  PubMed  CAS  Google Scholar 

  8. Lyoo IK, Seol HY, Byun HS, Renshaw PF. Unsuspected multiple sclerosis in patients with psychiatric disorders: a magnetic resonance imaging study. J Neuropsychiatry Clin Neurosci. 1996;8(1):54–9.

    PubMed  CAS  Google Scholar 

  9. •• Okuda DT, Mowry EM, Beheshtian A, et al. Incidental MRI anomalies suggestive of multiple sclerosis: the radiologically isolated syndrome. Neurology 2009;72(9):800–5. This study named and proposed diagnostic criteria for the RIS, and described the outcomes of a small cohort of patients with this condition.

    Article  PubMed  CAS  Google Scholar 

  10. Sellner J, Schirmer L, Hemmer B, Muhlau M. The radiologically isolated syndrome: take action when the unexpected is uncovered? J Neurol. 2010;257(10):1602–11.

    Article  PubMed  Google Scholar 

  11. Mackay RP, Hirano A. Forms of benign multiple sclerosis. Report of two “clinically silent” cases discovered at autopsy. Arch Neurol. 1967;17(6):588–600.

    PubMed  CAS  Google Scholar 

  12. Morariu M, Klutzow WF. Subclinical multiple sclerosis. J Neurol. 1976;213(1):71–6.

    Article  PubMed  CAS  Google Scholar 

  13. Castaigne P, Lhermitte F, Escourolle R, Castaigne P, Lhermitte F, Escourolle R, et al. Asymptomatic multiple sclerosis—3 cases (author’s transl). Rev Neurol (Paris). 1981;137(12):729–39.

    CAS  Google Scholar 

  14. Gilbert JJ, Sadler M. Unsuspected multiple sclerosis. Arch Neurol. 1983;40(9):533–6.

    PubMed  CAS  Google Scholar 

  15. Engell T. A clinical patho-anatomical study of clinically silent multiple sclerosis. Acta Neurol Scand. 1989;79(5):428–30.

    Article  PubMed  CAS  Google Scholar 

  16. Heinsen H, Lockemann U, Puschel K. Unsuspected (clinically silent) multiple sclerosis. Quantitative investigations in one autoptic case. Int J Legal Med. 1995;107(5):263–6.

    Article  PubMed  CAS  Google Scholar 

  17. Barkhof F, Scheltens P, Kamphorst W. Pre-and post-mortem MR imaging of unsuspected multiple sclerosis in a patient with Alzheimer’s disease. J Neurol Sci. 1993;117(1–2):175–8.

    Article  PubMed  CAS  Google Scholar 

  18. Lycklama à Nijeholt G, Barkhof F. Differences between subgroups of MS: MRI findings and correlation with histopathology. J Neurol Sci. 2003;206(2):173–4.

    Article  PubMed  Google Scholar 

  19. Seewann A, Kooi EJ, Roosendaal SD, et al. Translating pathology in multiple sclerosis: the combination of postmortem imaging, histopathology and clinical findings. Acta Neurol Scand. 2009;119(6):349–55.

    Article  PubMed  CAS  Google Scholar 

  20. Herndon RM, Rudick RA. Multiple sclerosis: the spectrum of severity. Arch Neurol. 1983;40(9):531–2.

    PubMed  CAS  Google Scholar 

  21. Wasay M, Rizvi F, Azeemuddin M, et al. Incidental MRI lesions suggestive of multiple sclerosis in asymptomatic patients in Karachi, Pakistan. J Neurol Neurosurg Psychiatry. 2011;82(1):83–5.

    Article  PubMed  CAS  Google Scholar 

  22. Traboulsee AL, Li DK. The role of MRI in the diagnosis of multiple sclerosis. Adv Neurol. 2006;98:125–46.

    PubMed  Google Scholar 

  23. de Seze J, Vermersch P. Sequential magnetic resonance imaging follow-up of multiple sclerosis before the clinical phase. Mult Scler. 2005;11(4):395–7.

    Article  PubMed  Google Scholar 

  24. McDonnell GV, Cabrera-Gomez J, Calne DB, et al. Clinical presentation of primary progressive multiple sclerosis 10 years after the incidental finding of typical magnetic resonance imaging brain lesions: the subclinical stage of primary progressive multiple sclerosis may last 10 years. Mult Scler. 2003;9(2):204–9.

    Article  PubMed  CAS  Google Scholar 

  25. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997;120(Pt 11):2059–69.

    Article  PubMed  Google Scholar 

  26. Lebrun C, Bensa C, Debouverie M, et al. Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile. J Neurol Neurosurg Psychiatry. 2008;79(2):195–8.

    Article  PubMed  CAS  Google Scholar 

  27. Tintore M, Rovira A, Martinez MJ, et al. Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol. 2000;21(4):702–6.

    PubMed  CAS  Google Scholar 

  28. •• Okuda DT, Mowry EM, Cree BA, et al. Asymptomatic spinal cord lesions predict disease progression in radiologically isolated syndrome. Neurology 2011;76(8):686–92. This study indicates that it may be possible to risk stratify patients with RIS based on lesion location. Further risk stratification will be important when deciding on therapeutic intervention for RIS.

    Article  PubMed  CAS  Google Scholar 

  29. Bourdette D, Yadav V. The radiologically isolated syndrome revisited: when is it presymptomatic multiple sclerosis? Neurology. 2011;76(8):680–1.

    Article  PubMed  Google Scholar 

  30. Siva A, Saip S, Altintas A, et al. Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease. Mult Scler. 2009;15(8):918–27.

    Article  PubMed  CAS  Google Scholar 

  31. Sierra-Marcos A, Mitjana R, Castillo J, et al. Demyelinating lesions as incidental findings in magnetic resonance imaging: a study of 11 cases with clinico-radiological follow-up and a review of the literature. Rev Neurol. 2010;51(3):129–34.

    PubMed  Google Scholar 

  32. Schumacker GA, Beebe G, Kibler RF, et al. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552–68.

    Article  PubMed  CAS  Google Scholar 

  33. CHAMPS Study Group. MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group. Neurology. 2002;59(7):998–1005.

    Google Scholar 

  34. McDonald WI, Compston A, Edan G, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001;50(1):121–7.

    Article  PubMed  CAS  Google Scholar 

  35. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–6.

    Article  PubMed  Google Scholar 

  36. Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292–302.

    Article  PubMed  Google Scholar 

  37. Swanton JK, Rovira A, Tintore M, et al. MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol. 2007;6(8):677–86.

    Article  PubMed  Google Scholar 

  38. Swanton JK, Fernando K, Dalton CM, et al. Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes. J Neurol Neurosurg Psychiatry. 2006;77(7):830–3.

    Article  PubMed  CAS  Google Scholar 

  39. Rolak LA, Fleming JO. The differential diagnosis of multiple sclerosis. Neurologist. 2007;13(2):57–72.

    Article  PubMed  Google Scholar 

  40. Kappos L, Antel J, Comi G, et al. Oral fingolimod (FTY720) for relapsing multiple sclerosis. N Engl J Med. 2006;355(11):1124–40.

    Article  PubMed  CAS  Google Scholar 

  41. Kappos L, Gold R, Miller DH, et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet. 2008;372(9648):1463–72.

    Article  PubMed  CAS  Google Scholar 

  42. • Chard DT, Dalton CM, Swanton J, et al. MRI only conversion to multiple sclerosis following a clinically isolated syndrome. J Neurol Neurosurg Psychiatry 2011;82(2):176–9. This looks at the long-term outcomes of CIS, which are important when conducting risk/benefit considerations of MS therapies in early stages of disease.

    Article  PubMed  CAS  Google Scholar 

  43. Charil A, Yousry TA, Rovaris M, et al. MRI and the diagnosis of multiple sclerosis: expanding the concept of “no better explanation”. Lancet Neurol. 2006;5(10):841–52.

    Article  PubMed  Google Scholar 

  44. Korteweg T, Uitdehaag BM, Knol DL, et al. Interobserver agreement on the radiological criteria of the International Panel on the diagnosis of multiple sclerosis. Eur Radiol. 2007;17(1):67–71.

    Article  PubMed  Google Scholar 

  45. Seewann A, Enzinger C, Filippi M, et al. MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain: a review of reported findings. J Neurol. 2008;255(1):1–10.

    Article  PubMed  CAS  Google Scholar 

  46. Lebrun C, Blanc F, Brassat D, et al. CFSEP: cognitive function in radiologically isolated syndrome. Mult Scler. 2010;16(8):919–25.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

We thank Bronwyn Hamilton, MD, for sharing information about the prevalence of RIS among patients undergoing MRI for headache at Oregon Health & Science University. Dr. Spain has a Career Development Award from the Department of Veterans Affairs Rehabilitation Research & Development Service.

Disclosure

No potential conflicts of interest relevant to this article were reported.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rebecca Spain.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Spain, R., Bourdette, D. The Radiologically Isolated Syndrome: Look (Again) Before You Treat. Curr Neurol Neurosci Rep 11, 498–506 (2011). https://doi.org/10.1007/s11910-011-0213-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-011-0213-z

Keywords

Navigation